माल्टा - अंग्रेज़ी - Medicines Authority

sandoz limited 200 frimley business park, frimley camberley, surrey gu16 7sr, united kingdom - bimatoprost - eye drops, solution - bimatoprost 0.3 mg/ml - ophthalmologicals

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

gm pharma international pty ltd - bimatoprost, quantity: 0.3 mg/ml - eye drops - excipient ingredients: hydrochloric acid; dibasic sodium phosphate heptahydrate; citric acid monohydrate; benzalkonium chloride; water for injections; sodium chloride; sodium hydroxide - for the reduction of elevated intraocular pressure, or open angle glaucoma, as first line therapy or monotherapy or as adjunctive therapy to topical beta- blockers.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - bimatoprost, quantity: 0.3 mg/ml - eye drops - excipient ingredients: water for injections; hydrochloric acid; benzalkonium chloride; citric acid monohydrate; sodium chloride; dibasic sodium phosphate heptahydrate; sodium hydroxide - for the reduction of elevated intraocular pressure, or open angle glaucoma, as first line therapy or monotherapy or as adjunctive therapy to topical beta- blockers.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - bimatoprost, quantity: 0.3 mg/ml - eye drops - excipient ingredients: hydrochloric acid; dibasic sodium phosphate heptahydrate; sodium hydroxide; sodium chloride; citric acid monohydrate; water for injections; benzalkonium chloride - for the reduction of elevated intraocular pressure, or open angle glaucoma, as first line therapy or monotherapy or as adjunctive therapy to topical beta- blockers.

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

alembic pharmaceuticals limited - bimatoprost (unii: qxs94885mz) (bimatoprost - unii:qxs94885mz) - bimatoprost ophthalmic solution, 0.03% is indicated to treat hypotrichosis of the eyelashes by increasing their growth including length, thickness and darkness. bimatoprost ophthalmic solution, 0.03% is contraindicated in patients with hypersensitivity to bimatoprost or to any of the ingredients [see adverse reactions 6.2) ]. risk summary there are no adequate and well-controlled studies of bimatoprost ophthalmic solution 0.03% administration in pregnant women. there is no increase in the risk of major birth defects or miscarriages based on bimatoprost postmarketing experience. in embryofetal development studies, administration of bimatoprost to pregnant mice and rats during organogenesis resulted in abortion and early delivery at oral doses at least 33 times (mice) or 94 times (rats) the human exposure following topical ophthalmic administration of bimatoprost 0.03% to the cornea or conjunctival sac bilaterally once daily, based on the area under the curve (auc). these adverse effects were not observ

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

alembic pharmaceuticals limited - bimatoprost (unii: qxs94885mz) (bimatoprost - unii:qxs94885mz) - bimatoprost ophthalmic solution, 0.03% is indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension.  bimatoprost ophthalmic solution, 0.03% is contraindicated in patients with hypersensitivity to bimatoprost or to any of the ingredients [see adverse reactions (6.2) ]. risk summary there are no adequate and well-controlled studies of bimatoprost ophthalmic solution, 0.03% administration in pregnant women. there is no increase in the risk of major birth defects or miscarriages based on bimatoprost postmarketing experience. in embryofetal developmental studies, administration of bimatoprost in pregnant mice and rats during organogenesis, resulted in abortion and early delivery at oral doses at least 33 times (mice) or 94 times (rats) the human exposure at the recommended clinical dose (based on blood area under the curve [auc] levels). these adverse effects were not observed at 2.6 times (mice) and 47 times (rats) the human exposure at the

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

multichem nz limited - bimatoprost 0.3 mg/ml;  ;   - eye drops, solution - 0.3 mg/ml - active: bimatoprost 0.3 mg/ml     excipient: benzalkonium chloride citric acid monohydrate dibasic sodium phosphate heptahydrate hydrochloric acid purified water sodium chloride sodium hydroxide - monotherapy for the reduction of elevated intraocular pressure (iop) in patients with chronic glaucoma or ocular hypertension; or as adjunctive therapy in patients not adequately controlled on other agents.

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

ax pharmaceutical corp - bimatoprost (unii: qxs94885mz) (bimatoprost - unii:qxs94885mz) - bimatoprost .99 g in 1 g

बेल्जियम - अंग्रेज़ी - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - bimatoprost 0,1 mg/ml - eye drops, solution - 0,1 mg/ml - bimatoprost 0.1 mg/ml - bimatoprost

बेल्जियम - अंग्रेज़ी - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - bimatoprost 0,3 mg/ml - eye drops, solution - 0,3 mg/ml - bimatoprost 0.3 mg/ml - bimatoprost